Privium Fund Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.17M | Sell |
|
|||||
|
2025
Q1 | $2.05M | Buy |
|
|||||
|
2024
Q4 | $1.38M | Buy |
|
|||||
|
2024
Q3 | $1.43M | Buy |
|
|||||
|
2024
Q2 | $1.45M | Buy |
|
|||||
|
2024
Q1 | $869K | Hold |
|
|||||
|
2023
Q4 | $842K | Buy |
|
|||||
|
2023
Q3 | $327K | Buy |
|
|||||
|
2023
Q2 | $342K | Hold |
|
|||||
|
2023
Q1 | $271K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $235K | Buy |
|